Market Cap : 126.49 B | Enterprise Value : 139.53 B | PE Ratio : 25.53 | PB Ratio : 2.42 |
---|
NYSE:MDT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:MDT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Medtronic's Total Stockholders Equity for the quarter that ended in Apr. 2022 was $52,551 Mil. Medtronic's Total Assets for the quarter that ended in Apr. 2022 was $90,981 Mil. Therefore, Medtronic's Equity to Asset Ratio for the quarter that ended in Apr. 2022 was 0.58.
The historical rank and industry rank for Medtronic's Equity-to-Asset or its related term are showing as below:
During the past 13 years, the highest Equity to Asset Ratio of Medtronic was 0.79. The lowest was 0.48. And the median was 0.63.
The historical data trend for Medtronic's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medtronic's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Medtronic's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Medtronic's Equity to Asset Ratio for the fiscal year that ended in Apr. 2022 is calculated as
Equity to Asset (A: Apr. 2022 ) | = | Total Stockholders Equity | / | Total Assets |
= | 52551 | / | 90981 | |
= | 0.58 |
Medtronic's Equity to Asset Ratio for the quarter that ended in Apr. 2022 is calculated as
Equity to Asset (Q: Apr. 2022 ) | = | Total Stockholders Equity | / | Total Assets |
= | 52551 | / | 90981 | |
= | 0.58 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Thank you for viewing the detailed overview of Medtronic's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 3M CENTER ST. PAUL MN 55144-1000 |
Kirk Jennifer M | officer: Chief Accounting Officer | 5 GREENWAY PLAZA SUITE 110 HOUSTON TX 77046 |
Lofton Kevin E | director | GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 |
Wall Brett A. | officer: EVP & Group Pres Restora Thera | 710 MEDTRONIC PARKWAY LC300 MINNEAPOLIS MN 55432 |
Salmon Sean | officer: EVP & Group President Diabetes | MEDTRONIC PLC, 710 MEDTRONIC PARKWAY LC300 MINNEAPOLIS MN 55432 |
Goldsmith Andrea Jo | director | 1220 AUGUSTA DRIVE SUITE 600 HOUSTON TX 77057 |
Liddicoat John R | officer: EVP & President of Americas | MEDTRONIC PLC 710 MEDTRONIC PKWY, MS LC300 MINNEAPOLIS MN 55432 |
White Robert John | officer: EVP & President MITG | MEDTRONIC PLC 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 |
Parkhill Karen L | officer: EVP & Chief Financial Officer | 1717 MAIN STREET, MC 6402 DALLAS TX 75201 |
Reddy Preetha | director | APOLLO HOSPITALS 21 GREAMS LN, OFF GREAMS RD CHENNAI K7 600006 |
Ellis Gary Lee | officer: EVP & Chief Financial Officer | THE TORO COMPANY 8111 LYNDALE AVENUE SOUTH BLOOMINGTON MN 55420 |
Hanson Bryan C | officer: EVP AND PRESIDENT, COVIDIEN | ZIMMER BIOMET HOLDINGS 345 E. MAIN STREET WARSAW IN 46580 |
Hakami Hooman | officer: EVP & Group President Diabetes | 710 MEDTRONIC PKWY MSLC300 MINNEAPOLIS MN 55432 |
Oconnell Christopher J | officer: See Remarks | MEDTRONIC, INC. 710 MEDTRONIC PKWY MINNEAPOLIS MN 55432 |
Lenehan James T | director | C/O MEDTRONIC INC 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 |
From GuruFocus
By PRNewswire 03-17-2022
Other Sources
By Seekingalpha 2022-02-22
By Zacks 2022-03-07
By Zacks 2022-04-05
By Zacks 2022-03-07
By Zacks 2022-03-03
By Zacks 2022-04-05
By Zacks 2022-03-10
By Zacks 2022-02-23
By Zacks 2022-02-22
By tipranks.com 2022-03-10
By Zacks 2022-02-22
By Zacks 2022-03-23
By Zacks 2022-03-18
By Zacks 2022-03-24